Reporting quality and evidence support in randomized controlled trials of Bupleurum-based herbal medicine formulas for epilepsy.
Jiang-Li Yang, Jing-Jing Liu, Li-Xiang Wang et al.
✦ AI-curated · Sources linked
In 30 seconds
This meta-analysis evaluated the efficacy of Bupleurum-based herbal formulas in treating epilepsy, analyzing 33 randomized controlled trials with 2464 patients. The results indicated that these formulas significantly improved overall clinical efficacy (OR = 3.49) compared to antiepileptic monotherapy, alongside notable reductions in seizure frequency and duration. However, the reporting quality was suboptimal.
Key findings
- Overall clinical efficacy was more than tripled with Bupleurum-based formulas (OR = 3.49, p < 0.001).
- Seizure frequency significantly reduced (SMD = -2.70, p < 0.001).
- Seizure duration also significantly decreased (SMD = -3.56, p < 0.001).
- Adverse event rates were comparable between herbal and control groups (OR = 0.82, p = 0.33).
Why it matters
The findings suggest that Bupleurum-based herbal formulas may offer significant benefits for patients with epilepsy, potentially enhancing treatment options. However, the poor reporting quality highlights the need for improved research standards in this area.
What to keep in mind
The overall reporting quality was suboptimal, with key deficiencies in randomization and blinding methods.